Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Catalyst design insights from modelling a titanium-catalyzed multicomponent reaction.

Aldrich KE, Kansal D, Odom AL.

Faraday Discuss. 2019 Dec 2;220(0):208-230. doi: 10.1039/c9fd00033j.

PMID:
31528974
2.

Electronic and Structural Comparisons between Iron(II/III) and Ruthenium(II/III) Imide Analogs.

Aldrich KE, Fales BS, Singh AK, Staples RJ, Levine BG, McCracken J, Smith MR 3rd, Odom AL.

Inorg Chem. 2019 Sep 3;58(17):11699-11715. doi: 10.1021/acs.inorgchem.9b01672. Epub 2019 Aug 12.

PMID:
31403782
3.

A silica-supported titanium catalyst for heterogeneous hydroamination and multicomponent coupling reactions.

Aldrich KE, Odom AL.

Dalton Trans. 2019 Aug 14;48(30):11352-11360. doi: 10.1039/c9dt01835b. Epub 2019 Jul 8.

PMID:
31281914
4.

A photochemical route to a square planar, ruthenium(iv)-bis(imide).

Aldrich KE, Odom AL.

Chem Commun (Camb). 2019 Apr 9;55(30):4403-4406. doi: 10.1039/c9cc01019j.

PMID:
30916084
5.

Partner with IT to reduce frustration, improve patient care.

Aldrich K.

Nursing. 2017 Dec;47(12):68-69. doi: 10.1097/01.NURSE.0000526895.15251.02. No abstract available.

PMID:
29189464
6.

Trade your open tickets for interoperability.

Aldrich K.

Nurs Manage. 2017 Oct;48(10):25-26. doi: 10.1097/01.NUMA.0000524822.79652.5b. No abstract available.

PMID:
28957829
7.

GAPNA Consensus Statement on Proficiencies for the APRN Gerontological Specialist: Proficiency Statement 6.

Aldrich KM, Sabol VK.

Geriatr Nurs. 2016 Sep - Oct;37(5):412-414. doi: 10.1016/j.gerinurse.2016.08.012. Epub 2016 Sep 9. No abstract available.

PMID:
27968944
8.

Meeting The Future of Nursing Report Recommendations: A Successful Practice-Academic Partnership.

Stout C, Short Nancy, Aldrich K, Cintron RJ, Provencio-Vasquez E.

Nurs Econ. 2015 May-Jun;33(3):161-6.

PMID:
26259340
9.

Defining and incorporating basic nursing care actions into the electronic health record.

Englebright J, Aldrich K, Taylor CR.

J Nurs Scholarsh. 2014 Jan;46(1):50-7. doi: 10.1111/jnu.12057. Epub 2013 Dec 19.

PMID:
24354951
10.

Overcoming barriers to electronic medical record (EMR) implementation in the US healthcare system: A comparative study.

Kumar S, Aldrich K.

Health Informatics J. 2010 Dec;16(4):306-18. doi: 10.1177/1460458210380523.

PMID:
21216809
11.

What determines auditory similarity? The effect of stimulus group and methodology.

Aldrich KM, Hellier EJ, Edworthy J.

Q J Exp Psychol (Hove). 2009 Jan;62(1):63-83. doi: 10.1080/17470210701814451. Epub 2008 Feb 20.

PMID:
18609397
12.

Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques.

Patterson LJ, Beal J, Demberg T, Florese RH, Malkevich N, Venzon D, Aldrich K, Richardson E, Kalyanaraman VS, Kalisz I, Lee EM, Montefiori DC, Robey FA, Robert-Guroff M.

Virology. 2008 May 10;374(2):322-37. doi: 10.1016/j.virol.2007.12.037. Epub 2008 Feb 5.

13.

How to try this: define your terms. Evaluating instruments for use in nursing practice.

Stotts NA, Aldrich KM.

Am J Nurs. 2007 Oct;107(10):71-2. No abstract available.

PMID:
17895736
14.

Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge.

Florese RH, Van Rompay KK, Aldrich K, Forthal DN, Landucci G, Mahalanabis M, Haigwood N, Venzon D, Kalyanaraman VS, Marthas ML, Robert-Guroff M.

J Immunol. 2006 Sep 15;177(6):4028-36.

15.

A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.

Gómez-Román VR, Florese RH, Patterson LJ, Peng B, Venzon D, Aldrich K, Robert-Guroff M.

J Immunol Methods. 2006 Jan 20;308(1-2):53-67. Epub 2005 Nov 28.

PMID:
16343526
16.

Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag.

Zhao J, Voltan R, Peng B, Davis-Warren A, Kalyanaraman VS, Alvord WG, Aldrich K, Bernasconi D, Buttò S, Cafaro A, Ensoli B, Robert-Guroff M.

Virology. 2005 Nov 10;342(1):1-12. Epub 2005 Aug 18.

17.

Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE.

Pinczewski J, Zhao J, Malkevitch N, Patterson LJ, Aldrich K, Alvord WG, Robert-Guroff M.

Viral Immunol. 2005;18(1):236-43.

PMID:
15802969
18.

Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251.

Gómez-Román VR, Patterson LJ, Venzon D, Liewehr D, Aldrich K, Florese R, Robert-Guroff M.

J Immunol. 2005 Feb 15;174(4):2185-9.

19.

Designing trend-monitoring sounds for helicopters: methodological issues and an application.

Edworthy J, Hellier E, Aldrich K, Loxley S.

J Exp Psychol Appl. 2004 Dec;10(4):203-18.

PMID:
15598119
20.

Linguistic and location effects in compliance with pesticide warning labels for amateur and professional users.

Edworthy J, Hellier E, Morley N, Grey C, Aldrich K, Lee A.

Hum Factors. 2004 Spring;46(1):11-31.

PMID:
15151153
21.

Evaluation of combination DNA/replication-competent Ad-SIV recombinant immunization regimens in rhesus macaques.

Malkevitch N, Rohne D, Pinczewski J, Aldrich K, Kalyanaraman VS, Letvin NL, Robert-Guroff M.

AIDS Res Hum Retroviruses. 2004 Feb;20(2):235-44.

PMID:
15018712
22.

Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants.

Zhao J, Lou Y, Pinczewski J, Malkevitch N, Aldrich K, Kalyanaraman VS, Venzon D, Peng B, Patterson LJ, Edghill-Smith Y, Woodward R, Pavlakis GN, Robert-Guroff M.

Vaccine. 2003 Sep 8;21(25-26):4022-35.

PMID:
12922139
23.

Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.

Patterson LJ, Malkevitch N, Pinczewski J, Venzon D, Lou Y, Peng B, Munch C, Leonard M, Richardson E, Aldrich K, Kalyanaraman VS, Pavlakis GN, Robert-Guroff M.

J Virol. 2003 Aug;77(16):8607-20.

24.

Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.

Zhao J, Pinczewski J, Gómez-Román VR, Venzon D, Kalyanaraman VS, Markham PD, Aldrich K, Moake M, Montefiori DC, Lou Y, Pavlakis GN, Robert-Guroff M.

J Virol. 2003 Aug;77(15):8354-65.

26.

Effects of intestinal survival surgery on systemic and mucosal immune responses in SIV-infected rhesus macaques.

Edghill-Smith YY, Aldrich K, Zhao J, Pinczewski J, Kalyanaraman VS, Johnson M, Heyliger A, Perrin RP, Woodward R, Robert-Guroff M.

J Med Primatol. 2002 Dec;31(6):313-22.

PMID:
12519209
27.

Hematological and blood viscosity changes in tail-suspended rats.

Saunders DK, Roberts AC, Aldrich KJ, Cuthbertson B.

Aviat Space Environ Med. 2002 Jul;73(7):647-53.

PMID:
12137100
28.

A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge.

Patterson LJ, Robey F, Muck A, Van Remoortere K, Aldrich K, Richardson E, Alvord WG, Markham PD, Cranage M, Robert-Guroff M.

AIDS Res Hum Retroviruses. 2001 Jun 10;17(9):837-49.

PMID:
11429125
29.

Comparison of erythrocyte osmotic fragility among ectotherms and endotherms at three temperatures.

Aldrich K, Saunders DK.

J Therm Biol. 2001 Jun;26(3):179-182.

PMID:
11240223
30.

Characterization of the Mycobacterium tuberculosis iniBAC promoter, a promoter that responds to cell wall biosynthesis inhibition.

Alland D, Steyn AJ, Weisbrod T, Aldrich K, Jacobs WR Jr.

J Bacteriol. 2000 Apr;182(7):1802-11.

31.

Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques.

Patterson LJ, Peng B, Abimiku AG, Aldrich K, Murty L, Markham PD, Kalyanaraman VS, Alvord WG, Tartaglia J, Franchini G, Robert-Guroff M.

AIDS. 2000 Nov 10;14(16):2445-55.

PMID:
11101054
32.

Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.

Buge SL, Murty L, Arora K, Kalyanaraman VS, Markham PD, Richardson ES, Aldrich K, Patterson LJ, Miller CJ, Cheng SM, Robert-Guroff M.

J Virol. 1999 Sep;73(9):7430-40.

33.

Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus.

Robert-Guroff M, Kaur H, Patterson LJ, Leno M, Conley AJ, McKenna PM, Markham PD, Richardson E, Aldrich K, Arora K, Murty L, Carter L, Zolla-Pazner S, Sinangil F.

J Virol. 1998 Dec;72(12):10275-80.

34.

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization.

Lubeck MD, Natuk R, Myagkikh M, Kalyan N, Aldrich K, Sinangil F, Alipanah S, Murthy SC, Chanda PK, Nigida SM Jr, Markham PD, Zolla-Pazner S, Steimer K, Wade M, Reitz MS Jr, Arthur LO, Mizutani S, Davis A, Hung PP, Gallo RC, Eichberg J, Robert-Guroff M.

Nat Med. 1997 Jun;3(6):651-8.

PMID:
9176492
35.
36.

HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques.

Abimiku AG, Franchini G, Tartaglia J, Aldrich K, Myagkikh M, Markham PD, Chong P, Klein M, Kieny MP, Paoletti E, et al.

Nat Med. 1995 Apr;1(4):321-9.

PMID:
7585061
37.

Humoral and cellular immune responses in rhesus macaques infected with human immunodeficiency virus type 2.

Abimiku AG, Franchini G, Aldrich K, Myagkikh M, Markham P, Gard E, Gallo RC, Robert-Guroff M.

AIDS Res Hum Retroviruses. 1995 Mar;11(3):383-93.

PMID:
7786583
38.

Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways.

Watkins BA, Reitz MS Jr, Wilson CA, Aldrich K, Davis AE, Robert-Guroff M.

J Virol. 1993 Dec;67(12):7493-500.

39.

Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.

Robert-Guroff M, Aldrich K, Muldoon R, Stern TL, Bansal GP, Matthews TJ, Markham PD, Gallo RC, Franchini G.

J Virol. 1992 Jun;66(6):3602-8.

40.

The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope.

Wilson C, Reitz MS Jr, Aldrich K, Klasse PJ, Blomberg J, Gallo RC, Robert-Guroff M.

J Virol. 1990 Jul;64(7):3240-8.

41.

The effect of time of day on hypnotizability: a brief communication.

Aldrich KJ, Bernstein DA.

Int J Clin Exp Hypn. 1987 Jul;35(3):141-5. No abstract available.

PMID:
3623731
42.

The effectiveness of patient interviews. A controlled study of emotional support during pregnancy.

Carpenter J, Aldrich K, Boverman H.

Arch Gen Psychiatry. 1968 Jul;19(1):110-2. No abstract available.

PMID:
5658375
43.

METHICILLIN-INDUCED LYSOZYME-SENSITIVE FORMS OF STAPHYLOCOCCI.

ALDRICH KM, SWORD CP.

J Bacteriol. 1964 Mar;87:690-5.

44.

Problems of social adjustment following lobotomy.

ALDRICH KA.

Am J Psychiatry. 1950 Dec;107(6):459-62. No abstract available.

PMID:
14838151
45.

PSEUDOLARIX AMABILIS, A NEW HOST FOR DASYSCYPHA WILLKOMMII.

Miller JA, Aldrich KF.

Science. 1936 May 22;83(2160):499. No abstract available.

PMID:
17813968

Supplemental Content

Loading ...
Support Center